2024-02-08 11:29:12 ET
More on Autolus Therapeutics
- Autolus Upgrades Leadership And Faces CAR-T Approval
- SA Analysts Comment On FDA Seeking Boxed Warning For CAR-T Cancer Therapies, Related Impact On AUTL
- Autolus Therapeutics: Pivotal Trial Using Familiar Approach, Possible Approval Coming Fast
- BioNTech to invest $200M in Autolus as part of a CAR-T deal
- Autolus cell therapy accepted for FDA review in leukemia
Read the full article on Seeking Alpha
For further details see:
Autolus prices underwritten offering to raise $350M to fund development of obe-cel program